Trade accounts receivable less allowance for doubtful accounts of $465,790 in 2016 and $465,790 in 2015
Accounts receivable from related parties
Inventories
Other current assets
Deferred tax asset, current
Total current assets
Property, plant and equipment, net
Carrying Amount
Goodwill
Deferred tax asset, non-current
thereof investment in equity method investees
Other assets
Total assets
Accounts payable
Accounts payable to related parties
Accrued expenses and other current liabilities
Short-term borrowings and other financial liabilities
Short-term borrowings from related parties
Current portion of long-term debt and capital lease obligations
Trust Preferred Securities
Income tax payable, current
Deferred tax liability, current
Total current liabilities
Long-term debt and capital lease obligations, less current portion
Long-term debt and capital lease obligations less current maturities
Other liabilities
Pension liabilities
Income tax payable, non-current
Deferred tax liability, non-current
Company-obligated mandatorily redeemable preferred securities of subsidiary Fresenius Medical Care Capital Trusts holding solely Company-guaranteed debentures of subsidiaries
Total liabilities
Preferred stock, no par value, 1.00 Euro nominal value, 7,066,522 shares authorized, 3,973,333 issued and outstanding
Noncontrolling interests subject to put provisions ending
Common stock, no par value, 1.00 Euro nominal value, 385,913,972 shares authorized, 307,141,323 issued and 306,141,372 outstanding
Treasury stock, at cost
Long term debt from related parties
Additional paid-in capital
Retained earnings
Accumulated other comprehensive (loss)
Total Company shareholders' equity
Noncontrolling interests not subject to put provisions
Total equity
Assets
Cash and cash equivalents
Trade accounts receivable, less allowance for doubtful accounts of 474,891 in 2017 and 482,461 in 2016
Trade accounts and other receivables
Trade accounts and other receivables from unrelated parties
Accounts receivable from related parties
Inventories
Other current assets
Other current financial assets
Assets held for sale
Total current assets
Property, plant and equipment
Right-of-use assets
Intangible assets
Goodwill
Deferred taxes
Investment in equity method investees
Other non-current assets
Other non-current financial assets
Total non-current assets
Total assets
Liabilities
Accounts payable
Accounts payable to unrelated parties
Accounts payable to related parties
Short-term debt
Current provisions and other current liabilities
Other current financial liabilities
Short-term debt from unrelated parties
Short-term debt from related parties
Current portion of long-term debt
Current portion of long-term lease liabilities
Current portion of lease liabilities from unrelated parties
Current portion of lease liabilities from related parties
Income tax liabilities
Liabilities directly associated with assets held for sale
Total current liabilities
Long-term debt, less current portion
Long-term lease liabilities, less current portion
Lease liabilities from unrelated parties, less current portion
Lease liabilities from related parties, less current portion
Non-current provisions and other non-current liabilities
Other non-current financial liabilities
Pension liabilities
Deferred taxes
Total non-current liabilities
Total liabilities
Shareholders' equity:
Ordinary shares, no par value, €1.00 nominal value, 382,754,793 shares authorized, 293,413,449 issued and 279,288,885 outstanding as of December 31, 2025 (December 31, 2024: 362,370,124 shares authorized, 293,413,449 issued and outstanding)
